Literature DB >> 12508201

Acute profound thrombocytopenia after use of eptifibatide for coronary stenting.

Emmanuel Salengro1, Niall T Mulvihill, Bruno Farah.   

Abstract

This is a case report of a patient who developed profound thrombocytopenia during treatment with eptifibatide after PCI of the mid right coronary artery. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12508201     DOI： 10.1002/ccd.10390

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  4 in total

Review 1.  Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.

Authors:  Michael W Tempelhof; Keith H Benzuly; Dan Fintel; Marc Z Krichavsky
Journal:  Tex Heart Inst J       Date:  2012

2.  Eptifibatide-induced thrombocytopenia and thrombosis.

Authors:  Slava Epelman; Deepu Nair; Ross Downey; Mike Militello; Arman T Askari
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

3.  Eptifibatide-induced thrombocytopenia.

Authors:  Marwan Refaat; A J Conrad Smith; Daniel Edmundowicz
Journal:  J Thromb Thrombolysis       Date:  2007-11-16       Impact factor: 2.300

Review 4.  Antiplatelet drug induced isolated profound thrombocytopenia in interventional cardiology: a review based on individual case reports.

Authors:  Thomas Höchtl; Linda Pachinger; Gerhard Unger; Alexander Geppert; Johann Wojta; Job Harenberg; Kurt Huber
Journal:  J Thromb Thrombolysis       Date:  2007-01-20       Impact factor: 5.221
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.